|
1
|
Hoofnagle JH: Hepatitis C: The clinical
spectrum of disease. Hepatology. 26 Suppl 1:15S–20S. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
World Health Organization, . Global health
sector strategies on viral hepatitis 2016–2021. August 29–2017
|
|
3
|
Safi SZ, Badshah Y, Waheed Y, Fatima K,
Tahir S, Shinwari A and Qadri I: Distribution of hepatitis C virus
genotypes, hepatic steatosis and their correlation with clinical
and virological factors in Pakistan. Asian Biomed. 4:253–262.
2010.
|
|
4
|
Smith DB and Simmonds P: Review: Molecular
epidemiology of hepatitis C virus. J Gastroenterol Hepatol.
12:522–527. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Waheed Y: Effect of interferon plus
ribavirin therapy on hepatitis C virus genotype 3 patients from
Pakistan: Treatment response, side effects and future prospective.
Asian Pac J Trop Med. 8:85–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Waheed Y: Ledipasvir and sofosbuvir:
Interferon free therapy for hepatitis C virus genotype 1 infection.
World J Virol. 4:33–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Waheed Y, Najmi MH, Aziz H, Waheed H,
Imran M and Safi SZ: Prevalence of hepatitis C in people who inject
drugs in the cities of Rawalpindi and Islamabad, Pakistan. Biomed
Rep. 7:263–266. 2017.PubMed/NCBI
|
|
8
|
Saeed U, Waheed Y, Ashraf M, Waheed U,
Anjum S and Afzal MS: Estimation of hepatitis B virus, hepatitis C
virus, and different clinical parameters in the thalaseemic
population of capital twin cities of Pakistan. Virology (Auckl).
6:11–16. 2015.PubMed/NCBI
|
|
9
|
Bartenschlager R, Ahlborn-Laake L, Mous J
and Jacobsen H: Nonstructural protein 3 of the hepatitis C virus
encodes a serine-type proteinase required for cleavage at the NS3/4
and NS4/5 junctions. J Virol. 67:3835–3844. 1993.PubMed/NCBI
|
|
10
|
Failla C, Tomei L and De Francesco R: An
amino-terminal domain of the hepatitis C virus NS3 protease is
essential for interaction with NS4A. J Virol. 69:1769–1777.
1995.PubMed/NCBI
|
|
11
|
Kim JL, Morgenstern KA, Lin C, Fox T,
Dwyer MD, Landro JA, Chambers SP, Markland W, Lepre CA, O'Malley
ET, et al: Crystal structure of the hepatitis C virus NS3 protease
domain complexed with a synthetic NS4A cofactor peptide. Cell.
87:343–355. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grakoui A, McCourt DW, Wychowski C,
Feinstone SM and Rice CM: Characterization of the hepatitis C
virus-encoded serine proteinase: Determination of
proteinase-dependent polyprotein cleavage sites. J Virol.
67:2832–2843. 1993.PubMed/NCBI
|
|
13
|
Waheed Y, Saeed U, Anjum S, Afzal MS and
Ashraf M: Development of global consensus sequence and analysis of
highly conserved domains of the HCV NS5B protein. Hepat Mon.
12:e61422012.PubMed/NCBI
|
|
14
|
Eckart MR, Selby M, Masiarz F, Lee C,
Berger K, Crawford K, Kuo C, Kuo G, Houghton M and Choo QL: The
hepatitis C virus encodes a serine protease involved in processing
of the putative nonstructural proteins from the viral polyprotein
precursor. Biochem Biophys Res Commun. 192:399–406. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shimizu Y, Yamaji K, Masuho Y, Yokota T,
Inoue H, Sudo K, Satoh S and Shimotohno K: Identification of the
sequence on NS4A required for enhanced cleavage of the NS5A/5B site
by hepatitis C virus NS3 protease. J Virol. 70:127–132.
1996.PubMed/NCBI
|
